Cisplatin fachinformation ema
WebFachinformation Carboplatin HEXAL® 10 mg/ml 1 1. BEZEICHNUNG DES ARZNEIMITTELS Carboplatin HEXAL® 10 mg/ml Konzentrat zur Herstellung einer Infu-sionslösung 2. QUALITATIVE UND QUANTITATIVE ZU-SAMMENSETZUNG 1 ml Konzentrat zur Herstellung einer In-fusionslösung enthält 10 mg Carboplatin. Jede 5 ml … WebCisplatin is a cancer medicine that has been used to treat various types of cancer for several years. It belongs to a class of medicines called 'alkylating agents' and works by …
Cisplatin fachinformation ema
Did you know?
WebMar 30, 2024 · FDA approves durvalumab for extensive-stage small cell lung cancer On March 27, 2024, the Food and Drug Administration approved durvalumab (IMFINZI, AstraZeneca) in combination with etoposide and... Web1. European Medicines Agency 2. National Competent Authorities II. Medicines compendia or dictionary III. SmPCs are the main source of information of: 1. Medical and pharmaceutical references 2. Electronic prescribing support tools IV. All parts of advertising must comply with the SmPC V. The package leaflets are based from SmPC information
WebProduct information - European Medicines Agency WebSep 17, 2024 · Overview. Tecentriq is a medicine for treating the following cancers: • urothelial cancer (cancer of the bladder and urinary system); • non-small cell lung cancer …
WebMar 15, 2024 · On 30 April 2024, EMA recommended that patients should be tested for the lack of the enzyme dihydropyrimidine dehydrogenase (DPD) before starting cancer … WebOverview. Braftovi is a medicine for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. Braftovi is used in combination …
WebCisplatin 1mg/ml Injection BP NL/H/0118/004 PL 14510/0017 EBEWE PHARMA UK Cisplatin Neocorp 1 mg/ml – Konzentrat zur Herstellung einer ... European Medicines Agency Keywords: Periodic safety update report single assessment; cisplatin; PSUSA/00000778/202412 Created Date:
Web'lh hpsirkohqh 'rvlhuxqj yrq 'rfhwd[ho ehwuljw pj p dov vw qgljh ,qixvlrq jhirojw yrq &lvsodwlq pj p dov elv vw qgljh ,qixvlrq ehlgh qxu dq 7dj jhirojw yrq )oxrurxudflo pj p sur 7dj dov … dga television director rate reailtyWebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have been used. 2.4 Advanced Bladder Cancer . Cisplatin for injection has been administered at 50 mg/m. 2 . to 70 mg/m. intravenously per cycle once every 3 to 4 weeks. dgas water heater testing thermocoupleWebImfinzi is a medicine used to treat lung cancer. It for use in adults with: non-small cell lung cancer (NSCLC) that cannot be removed by surgery but is not getting worse after … cia tool kitWeb– Cisplatin wird angewendet in Kom-bination mit anderen Chemothera-peutika oder einer Strahlentherapie zur Behandlung des Zervixkarzinoms. – Cisplatin kann als Mono- oder … dgate homesWebBALVERSA® (erdafitinib) tablets BALVERSA® (erdafitinib) tablets 2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE BALVERSA is indicated for the treatment of adult patients with locally advanced or cia trailblazer awardWebToripalimab, a recombinant, humanized programmed death receptor-1 (PD-1) monoclonal antibody that binds to PD-1 and prevents binding of PD-1 with programmed death ligands 1 (PD-L1) and 2 (PD-L2), is being developed by Shanghai Junshi Bioscience Co., Ltd in China for the treatment of various cancers. ciating for leather chairWebexperienced nephrotoxicity as a result of cisplatin therapy. The carcinogenic potential of carboplatin has not been studied but compounds with similar mechanisms of action and … dga tempest flight numbers